Page last updated: 2024-09-04
canertinib and pomalidomide
canertinib has been researched along with pomalidomide in 1 studies
Compound Research Comparison
Studies (canertinib) | Trials (canertinib) | Recent Studies (post-2010) (canertinib) | Studies (pomalidomide) | Trials (pomalidomide) | Recent Studies (post-2010) (pomalidomide) |
---|---|---|---|---|---|
124 | 9 | 65 | 623 | 121 | 552 |
Protein Interaction Comparison
Protein | Taxonomy | canertinib (IC50) | pomalidomide (IC50) |
---|---|---|---|
DNA damage-binding protein 1 | Homo sapiens (human) | 2.1 | |
Protein cereblon | Homo sapiens (human) | 1.85 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Jiang, B; Liu, H; Qiu, X; Qu, X; Song, X; Sun, N; Yang, X; Zhong, H | 1 |
Other Studies
1 other study(ies) available for canertinib and pomalidomide
Article | Year |
---|---|
Effective degradation of EGFR
Topics: Apoptosis; Autophagy; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; ErbB Receptors; Humans; Lysosomes; Molecular Structure; Morpholines; Mutation; Proteasome Endopeptidase Complex; Protein Kinase Inhibitors; Structure-Activity Relationship; Thalidomide | 2021 |